The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia
Open Access
- 29 February 1996
- Vol. 47 (2) , 169-178
- https://doi.org/10.1016/s0090-4295(99)80410-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasiaUrology, 1995
- Practice Trends in the Diagnosis and Management of Benign Prostatic Hyperplasia in the United StatesJournal of Urology, 1995
- Benign Prostatic Hyperplasia — Medical and Minimally Invasive Treatment OptionsNew England Journal of Medicine, 1995
- A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic HyperplasiaNew England Journal of Medicine, 1995
- The Accuracy of Self-Reported Disability DaysMedical Care, 1994
- The costs of prostatectomy for benign prostatic hyperplasiaThe Prostate, 1993
- Medical outcomes research and benign prostatic hyperplasiaThe Prostate, 1990
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- The Natural History of Untreated “Prostatism”British Journal of Urology, 1981
- Medical Economics Survey-Methods StudyMedical Care, 1978